Carbapenem resistant Acinetobacter Species infection in intensive care unit: The outcome and risk factors of mortality
DOI:
https://doi.org/10.3329/bjms.v19i1.43879Keywords:
Carbapenem; Acinetobacter spp.; multi-drug resistant mortalityAbstract
Objective: Acinetobacter spp. infection is a challenging problem in intensive care unit (ICU) because of its multi-drug resistant (MDR) in nature to antibiotic therapy including broadspectrum carbapenem group. The aims of the study were to determine the risk factors of mortality and the outcome of carbapenem-resistant Acinetobacter spp. (CRAs) infection in our ICU.
Materials and Method: This is a retrospective, cross-sectional study, done in 2 years from January 2008 to December 2009. The list of the patients was obtained from hospital nosocomial infection surveillance unit and ICU infection record. The data of the patients were subsequently reviewed from their respective medical records after approval from university ethics committee and hospital medical record unit.
Results and Discussion: A total of 92 patients were reviewed and only 54 were included and analyzed. The prevalence of CRAs over 24 months was 7.3%. Mortality was 50% among the reviewed patients and this contributed 13.6 % of the total ICU mortality. Age was significantly different between survival and non-survival groups; 43.07 (21.09) vs. 57.04 ± 14.33 year old (p = 0.006). Age was also the only significant independent risk factor associated with mortality in CRAs (adjusted OR = 1.045, 95% CI: 1.010, 1.081, p = 0.011). There were no other significant risk factors. The length of ICU stay was 17.00 (13.58) days whereas length of hospital stay was 41.37 (27.66) days in survival group.
Conclusion: CRAs caused 13.6% of total ICU mortality and older age group was the independent risk factor for mortality.
Bangladesh Journal of Medical Science Vol.19(1) 2020 p.98-104
Downloads
34
34
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.